Biotage moves to the large cap segment
As of today January 3, 2022, Biotage is included in Nasdaq Stockholm’s Large Cap segment. The Large Cap segment includes companies with a market capitalization of more than EUR 1 billion.Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.“Biotage continues to create value for our